Theriva Biologics Inc (TOVX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Operating Expenses | 4,218 | 5,820 | 5,178 | 7,317 | 4,986 |
| Operating Income | -4,218 | -5,820 | -5,178 | -7,317 | -4,986 |
| Other Income | 388 | 377 | 370 | 314 | 161 |
| Pre-tax Income | -3,830 | -5,443 | -4,808 | -7,003 | -4,825 |
| Income Tax | -527 | -359 | -330 | -558 | -335 |
| Net Income Continuous | -3,303 | -5,084 | -4,478 | -6,445 | -4,490 |
| Net Income | $-3,303 | $-5,084 | $-4,478 | $-6,445 | $-4,490 |
| EPS Basic Total Ops | -4.85 | -8.50 | -7.50 | -10.50 | -7.50 |
| EPS Basic Continuous Ops | -4.85 | -8.38 | -7.40 | -10.23 | -7.08 |
| EPS Diluted Total Ops | -4.85 | -8.50 | -7.50 | -10.50 | -7.50 |
| EPS Diluted Continuous Ops | -4.85 | -8.38 | -7.40 | -10.23 | -7.08 |
| EBITDA(a) | $-4,186 | $-5,788 | $-5,146 | $-7,292 | $-4,962 |